Presentation of the company and the development of linaprazan glurate from Redeye Growth Day 2024
![Cinclus Redeye Growth Day 02](/media/qwyksxsm/cinclus_redeye-growth-day-02.jpg?rmode=max&width=1053&v=1daadd2fe87c8e0)
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Growth Day 2024.
Cinclus Pharma: InFocus interview with CEO Christer Ahlberg at Redeye Growth Day 2024 – 30 May